Company
Headquarters: Wakefield, MA, United States
Employees: 5,600
$947.6 Million
USD as of Jan. 1, 2025
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of February 18, 2022, it operated 126 dispensaries and 26 cultivation sites in 23 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | $1.36 B |
EBITDA | $274.8 M |
Gross Profit TTM | $638.1 M |
Profit Margin | -14.82% |
Operating Margin | 2.79% |
Quarterly Revenue Growth | -0.80% |
Curaleaf Holdings, Inc. has the following listings and related stock indices.
Stock: OTC: CURLF wb_incandescent
Stock: CSE: CURA wb_incandescent